Journal of Benefit-Cost Analysis

2010 - 2024

From Cambridge University Press
Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 15, issue 2, 2024

Efficiency vs. Welfare in Benefit–Cost Analysis: The Case of Government Funding pp. 224-251

Zachary Liscow and Cass R. Sunstein

Why Office of Management and Budget’s (OMB) Social Welfare Function Is Not Society’s Social Welfare Function pp. 252-275

W. Kip Viscusi

Renewable Energy Support Through Feed-in Tariffs: A Retrospective Stakeholder Analysis pp. 276-301

Majid Hashemi, Glenn Jenkins and Frank Milne

Estimating Lost Dividends from Incomplete Energy Access Transitions pp. 302-334

Emily L. Pakhtigian, Marc Jeuland, Subhrendu K. Pattanayak and Jonathan Phillips

Adaptable Tool for Modeling the Benefits and Costs of Substance Use Disorder Recovery Programs pp. 335-350

Madison Ashworth, David Johnson and Robin Thompson

An Ancillary Effect of Patient Navigation Following Detox: Fewer Arrests pp. 351-373

Robert Rosenman, Carolyn Noonan, Clemma Muller, Rich Maclehose, Jodi Trojan, Erin Poole and Spero M. Manson

Volume 15, issue 1, 2024

Regulators Should Value Nonhuman Animals pp. 1-13

Cass R. Sunstein

Valuing a Reduction in the Risk and Severity of Asthma: A Large Scale Multi-Country Stated Preference Approach pp. 14-86

Gildas Appéré, Damien Dussaux, Alan Krupnick and Muriel Travers

Open Exceptions: Why Does the Brazilian Health Regulatory Agency (ANVISA) Exempts RIA and Ex Post Reviews? pp. 87-104

Natasha Schmitt Caccia Salinas and Lucas Thevenard Gomes

Policy Diffusion, Environmental Federalism, and Economic Efficiency – How Institutions Influence the Implementation of EU Legislation in Two Nordic Countries pp. 105-127

Lena Nerhagen and Johanna Jussila Hammes

The Influence of the Benefit–Cost Analysis on Policy Evaluation in the European Union pp. 128-141

Kristina Gogic

Valuing a Reduction in the Risk of Chronic Kidney Disease: A Large-Scale Multi-Country Stated Preference Approach pp. 142-162

Chris Dockins, Damien Dussaux, Charles Griffiths, Sandra Hoffmann and Nathalie Simon

Mask Mandate Costs pp. 163-191

Patrick Carlin, Shyam Raman, Kosali Simon, Ryan Sullivan and Coady Wing

Do Opportunity Costs of Regulations Appropriately Benefit or Inappropriately Burden Disadvantaged Consumers? pp. 192-203

Donald Kenkel

A Tale of the Tails: The Value of a Statistical Life at the Tails of the Age Distribution pp. 204-222

Thomas J. Kniesner and W. Kip Viscusi

The Health-Augmented Lifecycle Model – CORRIGENDUM pp. 223-223

J.P. Sevilla

Volume 14, issue S1, 2023

Save 4.2 Million Lives and Generate $1.1 Trillion in Economic Benefits for Only $41 Billion: Introduction to the Special Issue on the Most Efficient Policies for the Sustainable Development Goals pp. 1-15

Bjorn Lomborg

An Investment Case for the Scale-up and Use of Insecticide-Treated Nets Halfway into the SDG Targets pp. 16-54

Rima Shretta and Randolph Ngwafor Anye

Improving Learning in Low- and Lower-Middle-Income Countries pp. 55-80

Noam Angrist, Elisabetta Aurino, Harry Patrinos, George Psacharopoulos, Emiliana Vegas, Ralph Nordjo and Brad Wong

The Investment Case for E-Government Procurement: A Cost–Benefit Analysis pp. 81-107

Erica Bosio, Gavin Hayman and Nancy Dubosse

Benefit–Cost Analysis of Increased Trade: An Order-of-Magnitude Estimate of the Benefit–Cost Ratio pp. 108-135

James Feyrer, Vladimir Tyazhelnikov, Benjamin Aleman-Castilla and Brad Wong

Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model pp. 136-180

Bryan Patenaude, Salin Sriudomporn and Joshua Mak

Benefit–Cost Analysis of Increased Funding for Agricultural Research and Development in the Global South pp. 181-205

Mark W. Rosegrant, Brad Wong, Timothy Sulser, Nancy Dubosse and Travis J. Lybbert

Achieving Maternal and Neonatal Mortality Development Goals Effectively: A Cost-Benefit Analysis pp. 206-234

Nyovani Madise, Arindam Nandi, Brad Wong and Saleema Razvi

Investing in Nutrition: A Global Best Investment Case pp. 235-254

Bjorn Larsen, John Hoddinott and Saleema Razvi

Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries pp. 255-271

David Watkins, Sali Ahmed and Sarah Pickersgill

The Investment Case for Land Tenure Security in Sub-Saharan Africa: A Cost–Benefit Analysis pp. 272-300

Frank F.K. Byamugisha and Nancy Dubosse

A Benefit-Cost Analysis of Increased International Migration of Skilled Labor in Africa and the World pp. 301-336

Keith Maskus

One Million Lives Saved Per Year: A Cost–Benefit Analysis of the Global Plan to End Tuberculosis, 2023–2030 and Beyond pp. 337-354

Carel Pretorius, Nimalan Arinaminpathy, Sandip Mandal, Suvanand Sahu, Madhukar Pai, Roland Mathiasson and Brad Wong

Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model – CORRIGENDUM pp. 355-355

Bryan Patenaude, Salin Sriudomporn and Joshua Mak

Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries – CORRIGENDUM pp. 356-356

David Watkins, Sali Ahmed and Sarah Pickersgill

Volume 14, issue 3, 2023

Redistributive Regulations and Deadweight Loss pp. 407-436

Daniel J. Hemel

Differences by Race and Ethnicity in Title IX’s Effect on Women’s Health pp. 437-450

Delaney Beck, Joni Hersch and W Viscusi

Cost–Benefit Analysis of an “Average” Professional Sports Team or Stadium in the United States pp. 451-477

Cristian F. Sepulveda

Volume 14, issue 2, 2023

Seven Recommendations for Pricing Greenhouse Gas Emissions pp. 191-204

Arthur G. Fraas, John D. Graham, Kerry M. Krutilla, Randall Lutter, Jason F. Shogren, Linda Thunström and W Viscusi

Distribution and Disputation: Net Benefits, Equity, and Public Decision-Making pp. 205-229

Spencer Banzhaf

An Assessment of the Climate Damage Costs of European Short-Lived Climate Forcers pp. 230-250

Stefan Åström and Lovisa Källmark

The Welfare Cost of Beijing’s Lottery Policy: Evidence from a Contingent Valuation Survey pp. 251-274

Ping Qin, Yifei Quan, Antung A. Liu, Joshua Linn and Jun Yang

Ex Ante Costs Versus Ex Post Costs of the Large Municipal Waste Combustor Rule pp. 275-297

Cynthia Morgan and Carl Pasurka

A Test of Hirschman’s Hiding Hand Principle in World Bank-Financed Hydropower Projects pp. 298-317

Godwin Olasehinde-Williams and Glenn Jenkins

Assessing Risk, Effectiveness, and Benefits in Transportation Regulation pp. 318-335

Deborah Vaughn Aiken and Stephen Brumbaugh

A Benefit–Cost Analysis of Tulsa Pre-K, Based on Effects on High-School Graduation and College Attendance pp. 336-355

Timothy Bartik, William T. Gormley, Sara Amadon, Douglas Hummel-Price and James Fuller

When Patients are Assailants: Valuing Occupational Risks in Health Care pp. 356-385

Elissa P. Gentry and W Viscusi

The Elasticity of Marginal Utility of Income for Distributional Weighting and Social Discounting: A Meta-Analysis pp. 386-405

Daniel Acland and David Greenberg

Volume 14, issue 1, 2023

Inequality and the Value of a Statistical Life pp. 1-7

Cass R. Sunstein

Promoting Equity through Equitable Risk Tradeoffs pp. 8-34

Thomas Kniesner and W Viscusi

An Equity Blindspot: The Incidence of Regulatory Costs pp. 35-43

Caroline Cecot

The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation pp. 44-67

Darius Lakdawalla and Charles E. Phelps

Distributional weighting and welfare/equity tradeoffs: a new approach pp. 68-92

Daniel J. Acland and David Greenberg

All Cancers Are not Created Equal: How Do Survival Prospects Affect the Willingness to Pay to Avoid Cancer? pp. 93-113

Anna Alberini, Christoph Rheinberger and Milan Ščasný

When Can Benefit–Cost Analyses Ignore Secondary Markets? pp. 114-140

Matthew J. Kotchen and Arik Levinson

Discounting in Natural Resource Damage Assessment pp. 141-161

Eric Horsch, Daniel Phaneuf, Chris Giguere, Jason Murray, Cameron Duff and Cole Kroninger

Discounting in Natural Resource Damage Assessment – Erratum pp. 162-162

Eric Horsch, Daniel Phaneuf, Chris Giguere, Jason Murray, Cameron Duff and Cole Kroninger

The Net Benefits and Residual Cost from U.S. Border Management of the Initially Inadmissible pp. 163-189

Robert Farrow